← Leaderboards
Michele Caggana
Nysdoh/Health Research, Inc.
$4,856,614
Attributed
$4,856,614
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.5M · FY2022–23$5M$3.8M$2.5M$1.3M$0
'22
'23
Funding mix
By agency
NIH$4,856,614 · 1
By mechanism
N01$4,856,614 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Ganciclovir”
- Sarjan Shah · Auritec Pharmaceuticals, Inc.$1,525,000
- Dena E Cohen · Regenerative Medical Solutions, Inc.$1,174,714
- Abhijit A Date · University Of Illinois At Chicago$648,739
- Ranya Elsayed · Augusta University$550,627
- Park Kieun · Renovate Biosciences, Inc.$292,116
- Janet L Paluh · Sxrna Technologies, Inc.$250,000
Research focus
GanciclovirHepatosplenomegalyDevelopmental Delay DisordersFollow-UpHearingHearing ScreeningCongenital CytomegalovirusDetectionDiagnosisEvaluation5 Year OldAntiviral AgentsAnxietyHearing ImpairmentAdvisory CommitteesCochlear ImplantsCongenital InfectionContractorDevelopmental DisabilitiesChildEarly DiagnosisEthicsBirthHigh Risk Population